INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 18, 2009 |
SVP General Counsel and Secret
Trans History: 117
|
SVP General Counsel and Secret | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,705 | -- | 4,705 |
| Dec 18, 2009 |
SVP General Counsel and Secret
Trans History: 117
|
SVP General Counsel and Secret | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,295 | -- | 20,295 |
| Dec 18, 2009 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,377 | -- | 5,377 |
| Dec 18, 2009 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,123 | -- | 13,123 |
| Dec 18, 2009 |
SVP Clinical Development
Trans History: 208
|
SVP Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,457 | -- | 5,457 |
| Dec 18, 2009 |
SVP Clinical Development
Trans History: 208
|
SVP Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,543 | -- | 14,543 |
| Dec 18, 2009 |
VP Regul Devel & Med Safety
Trans History: 288
|
VP Regul Devel & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,705 | -- | 4,705 |
| Dec 18, 2009 |
VP Regul Devel & Med Safety
Trans History: 288
|
VP Regul Devel & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 23,795 | -- | 23,795 |
| Dec 18, 2009 |
Director, CEO and President, Ten Percent Owner
Trans History: 427
|
Director, CEO and President, Ten Percent Owner | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 125,000 | -- | 125,000 |
| Dec 18, 2009 |
SVP Res and Dev Sciences
Trans History: 660
|
SVP Res and Dev Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,705 | -- | 4,705 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.